225 related articles for article (PubMed ID: 22675422)
21. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.
Yang J; Zaja-Milatovic S; Thu YM; Lee F; Smykla R; Richmond A
Mol Cancer Ther; 2009 Mar; 8(3):636-47. PubMed ID: 19276165
[TBL] [Abstract][Full Text] [Related]
22. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
23. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
24. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms.
Moitra K; Scally M; McGee K; Lancaster G; Gold B; Dean M
PLoS One; 2011 Jan; 6(1):e16318. PubMed ID: 21298007
[TBL] [Abstract][Full Text] [Related]
25. ATP-binding cassette transporter ABCB5 gene is expressed with variability in malignant melanoma.
Vásquez-Moctezuma I; Meraz-Ríos MA; Villanueva-López CG; Magaña M; Martínez-Macias R; Sánchez-González DJ; García-Sierra F; Herrera-González NE
Actas Dermosifiliogr; 2010 May; 101(4):341-8. PubMed ID: 20487690
[TBL] [Abstract][Full Text] [Related]
26. ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.
Kleffel S; Lee N; Lezcano C; Wilson BJ; Sobolewski K; Saab KR; Mueller H; Zhan Q; Posch C; Elco CP; DoRosario A; Garcia SS; Thakuria M; Wang YE; Wang LC; Murphy GF; Frank MH; Schatton T
J Invest Dermatol; 2016 Apr; 136(4):838-846. PubMed ID: 26827764
[TBL] [Abstract][Full Text] [Related]
27. Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma.
Ravnan MC; Matalka MS
Clin Ther; 2012 Jul; 34(7):1474-86. PubMed ID: 22742884
[TBL] [Abstract][Full Text] [Related]
28. ABCB5 gene amplification in human leukemia cells.
Frank NY; Frank MH
Leuk Res; 2009 Oct; 33(10):1303-5. PubMed ID: 19477512
[No Abstract] [Full Text] [Related]
29. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract][Full Text] [Related]
31. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients.
Wilson BJ; Schatton T; Zhan Q; Gasser M; Ma J; Saab KR; Schanche R; Waaga-Gasser AM; Gold JS; Huang Q; Murphy GF; Frank MH; Frank NY
Cancer Res; 2011 Aug; 71(15):5307-16. PubMed ID: 21652540
[TBL] [Abstract][Full Text] [Related]
32. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
33. ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.
Louphrasitthiphol P; Chauhan J; Goding CR
Pigment Cell Melanoma Res; 2020 Jan; 33(1):112-118. PubMed ID: 31595650
[TBL] [Abstract][Full Text] [Related]
34. [Drug resistance of malignant melanoma. Mechanisms and possible modulation].
Schadendorf D; Czarnetzki BM
Hautarzt; 1994 Oct; 45(10):678-84. PubMed ID: 8002335
[TBL] [Abstract][Full Text] [Related]
35. ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells.
Yao J; Yao X; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Nan K; Huo X
Oncol Res; 2017 Mar; 25(3):305-316. PubMed ID: 28281973
[TBL] [Abstract][Full Text] [Related]
36. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
[TBL] [Abstract][Full Text] [Related]
37. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.
Landreville S; Agapova OA; Kneass ZT; Salesse C; Harbour JW
Pigment Cell Melanoma Res; 2011 Jun; 24(3):430-7. PubMed ID: 21575142
[TBL] [Abstract][Full Text] [Related]
38. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
39. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAF
Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet X; Matías-Guiu X; Martí RM; Macià A
J Invest Dermatol; 2020 Jun; 140(6):1253-1265. PubMed ID: 31877318
[TBL] [Abstract][Full Text] [Related]
40. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
